CASI Pharmaceuticals Inc
CASI0.810USD
-0.021-2.59%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
12.55MMarket Cap
LossP/E TTM
CASI Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
28.54M
-15.77%
EPS(YoY)
-2.56
-26.82%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of CASI Pharmaceuticals Inc?
According to CASI Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached 28.54M, with a year-on-year change of -15.77%.
What is the Earnings Per Share (EPS) of CASI Pharmaceuticals Inc?
According to CASI Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -2.559, with a year-on-year change of -26.82%.
What is the net income of CASI Pharmaceuticals Inc?
According to CASI Pharmaceuticals Inc's FY2024 earnings report, its net income was -39.26M, with a year-on-year change of -45.62%.
What is the net margin of CASI Pharmaceuticals Inc?
According to CASI Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was -137.57%, with a year-on-year change of -77.49%.
What is the gross margin of CASI Pharmaceuticals Inc?
According to CASI Pharmaceuticals Inc's FY2024 earnings report, its gross margin was 55.88%, with a year-on-year change of -5.59%.
What is the debt-to-asset ratio of CASI Pharmaceuticals Inc?
According to CASI Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was 34.25%, with a year-on-year change of 36.45%.
What is the Return on Equity (ROE) of CASI Pharmaceuticals Inc?
According to CASI Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was -301.80%, with a year-on-year change of -284.74%.
What is the Return on Assets (ROA) of CASI Pharmaceuticals Inc?
According to CASI Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was -60.89%, with a year-on-year change of -98.85%.
What is the operating profit of CASI Pharmaceuticals Inc?
According to CASI Pharmaceuticals Inc's FY2024 earnings report, its operating profit was -34.41M, with a year-on-year change of -36.12%.
What are the current assets of CASI Pharmaceuticals Inc?
According to CASI Pharmaceuticals Inc's FY2024 earnings report, its current assets were 39.58M, with a year-on-year change of -33.31%.
What are the total assets of CASI Pharmaceuticals Inc?
According to CASI Pharmaceuticals Inc's FY2024 earnings report, its total assets of CASI Pharmaceuticals Inc were 53.67M, with a year-on-year change of -28.69%.
What are the total liabilities of CASI Pharmaceuticals Inc?
According to CASI Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of CASI Pharmaceuticals Inc were 51.82M, with a year-on-year change of 1.41%.
What is the total equity of CASI Pharmaceuticals Inc?
According to CASI Pharmaceuticals Inc's FY2024 earnings report, its total equity of CASI Pharmaceuticals Inc was 1.85M, with a year-on-year change of -92.34%.
What is the net operating income of CASI Pharmaceuticals Inc?
According to CASI Pharmaceuticals Inc's FY2024 earnings report, its net operating income of CASI Pharmaceuticals Inc was -38.07M, with a year-on-year change of -45.24%.
What is the net investment of CASI Pharmaceuticals Inc?
According to CASI Pharmaceuticals Inc's FY2024 earnings report, its net investment of CASI Pharmaceuticals Inc was 11.24M, with a year-on-year change of 216.24%.
What is the net financing of CASI Pharmaceuticals Inc?
According to CASI Pharmaceuticals Inc's FY2024 earnings report, its net financing of CASI Pharmaceuticals Inc was 15.43M, with a year-on-year change of 1801.65%.
